The primary reason for seeking faster approval of cancer treatments is the dire need for new and effective therapies. Cancer remains a leading cause of death globally, and many existing treatments have limited effectiveness or severe side effects. Faster approval can expedite the availability of innovative treatments to patients, potentially saving lives and reducing the burden on healthcare systems.